<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27331404</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>6</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Association of HLA-G 3' Untranslated Region Polymorphisms with Systemic Lupus Erythematosus in a Japanese Population: A Case-Control Association Study.</ArticleTitle><Pagination><StartPage>e0158065</StartPage><MedlinePgn>e0158065</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0158065</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0158065</ELocationID><Abstract><AbstractText>HLA-G plays a role in fetal-maternal tolerance as well as immunoregulation, and has been suggested to be involved in autoimmune diseases and cancers. HLA-G encodes two potentially functional polymorphisms in the 3' untranslated region, 14bp insertion/deletion (14bp indel, rs371194629) and a single nucleotide polymorphism rs1063320, previously reported to affect HLA-G expression level or splicing isoform and to be associated with susceptibility to systemic lupus erythematosus (SLE). However, the results of SLE association studies are inconsistent, probably due to the small sample size of each study and lack of consideration of linkage disequilibrium (LD) with HLA-class II haplotypes in each population. In this study, we performed association studies of these polymorphisms on 843 patients with SLE and 778 healthy controls in a Japanese population, in many of whom HLA-DRB1 alleles have been genotyped at the four-digit level. LD was detected between DRB1*13:02, protective against multiple autoimmune diseases in the Japanese, and the rs1063320 G (D' = 0.86, r2 = 0.02) and with 14bp del (D' = 0.62, r2 = 0.01), but not between SLE-susceptible DRB1*15:01 and HLA-G. Although significant association with overall SLE was not detected, 14bp ins allele was significantly associated with SLE with the age of onset &lt;20 years, when compared with healthy controls (P = 0.0067, PFDR = 0.039, OR 1.44, additive model) or with SLE patients with the age of onset &#x2265;20 (P = 0.033, PFDR = 0.0495, OR 2.09, additive model). This association remained significant after conditioning on DRB1*13:02 or DRB1*15:01. On the other hand, significant association was detected between rs1063320 C and anti-RNP antibody and anti-Sm antibody positive SLE, which was dependent on negative LD with DRB1*13:02. eQTL analysis showed reduced HLA-G mRNA level in 14bp ins/ins individuals. In conclusion, our observations showed that HLA-G 14bp ins allele represents a genetic contribution on early-onset SLE independent of DRB1.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hachiya</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Master's Program in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawasaki</LastName><ForeName>Aya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Master's Program in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oka</LastName><ForeName>Shomi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center for Allergy and Rheumatology, Sagamihara Hospital, National Hospital Organization, Sagamihara, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondo</LastName><ForeName>Yuya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Master's Program in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine (Rheumatology), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine (Rheumatology), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Niigata Rheumatic Center, Shibata, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsumoto</LastName><ForeName>Isao</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Master's Program in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine (Rheumatology), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kusaoi</LastName><ForeName>Makio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amano</LastName><ForeName>Hirofumi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suda</LastName><ForeName>Akiko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Kanagawa, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Setoguchi</LastName><ForeName>Keigo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Allergy and Immunological Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagai</LastName><ForeName>Tatsuo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimada</LastName><ForeName>Kota</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Tokyo Metropolitan Tama Medical Center, Fuchu, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugii</LastName><ForeName>Shoji</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Tokyo Metropolitan Tama Medical Center, Fuchu, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okamoto</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Himeji Medical Center, National Hospital Organization, Himeji, Hyogo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiba</LastName><ForeName>Noriyuki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Morioka Hospital, National Hospital Organization, Morioka, Iwate, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suematsu</LastName><ForeName>Eiichi</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Rheumatology, Clinical Research Institute, Kyushu Medical Center, National Hospital Organization, Fukuoka, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohno</LastName><ForeName>Shigeru</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katayama</LastName><ForeName>Masao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Nagoya Medical Center, National Hospital Organization, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kono</LastName><ForeName>Hajime</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirohata</LastName><ForeName>Shunsei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takasaki</LastName><ForeName>Yoshinari</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Juntendo University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sumida</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Master's Program in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine (Rheumatology), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagaoka</LastName><ForeName>Shouhei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tohma</LastName><ForeName>Shigeto</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Research Center for Allergy and Rheumatology, Sagamihara Hospital, National Hospital Organization, Sagamihara, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furukawa</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Master's Program in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center for Allergy and Rheumatology, Sagamihara Hospital, National Hospital Organization, Sagamihara, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuchiya</LastName><ForeName>Naoyuki</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-6776-5580</Identifier><AffiliationInfo><Affiliation>Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Master's Program in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020413">3' Untranslated Regions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059951">HLA-G Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020413" MajorTopicYN="N">3' Untranslated Regions</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020029" MajorTopicYN="N">Base Pairing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="Y">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059951" MajorTopicYN="N">HLA-G Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054643" MajorTopicYN="N">INDEL Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015810" MajorTopicYN="N">Linkage Disequilibrium</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="Y">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040641" MajorTopicYN="N">Quantitative Trait Loci</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>Dr. Kawasaki received a research grant from SENSHIN Medical Research Foundation and the Takeda Science Foundation. Dr. Tsuchiya received a research grant from SENSHIN Medical Research Foundation, received speaker&#x2019;s honoraria from Eisai Co., Ltd., Daiichi Sankyo Co., Ltd. and Asahi Kasei Corporation, and an award from Japan College of Rheumatology. This does not alter the authors&#x2019; adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27331404</ArticleId><ArticleId IdType="pmc">PMC4917238</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0158065</ArticleId><ArticleId IdType="pii">PONE-D-16-11352</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lau CS, Yin G, Mok MY. Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus. 2006;15:715&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pubmed">17153840</ArticleId></ArticleIdList></Reference><Reference><Citation>Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 1992;35:311&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">1536669</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos PS, Shedlock AM, Langefeld CD. Genetics of autoimmune diseases: insights from population genetics. J Hum Genet. 2015;60:657&#x2013;664. 10.1038/jhg.2015.94</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jhg.2015.94</ArticleId><ArticleId IdType="pmc">PMC4660050</ArticleId><ArticleId IdType="pubmed">26223182</ArticleId></ArticleIdList></Reference><Reference><Citation>Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 2008;358:900&#x2013;909. 10.1056/NEJMoa0707865</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0707865</ArticleId><ArticleId IdType="pubmed">18204098</ArticleId></ArticleIdList></Reference><Reference><Citation>International Consortium for Systemic Lupus Erythematosus G, Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet. 2008;40:204&#x2013;210. 10.1038/ng.81</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.81</ArticleId><ArticleId IdType="pmc">PMC3712260</ArticleId><ArticleId IdType="pubmed">18204446</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando MM, Freudenberg J, Lee A, Morris DL, Boteva L, Rhodes B, et al. Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G. Ann Rheum Dis. 2012;71:777&#x2013;784. 10.1136/annrheumdis-2011-200808</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2011-200808</ArticleId><ArticleId IdType="pmc">PMC3329227</ArticleId><ArticleId IdType="pubmed">22233601</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM, et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet. 2008;4:e1000024 10.1371/journal.pgen.1000024</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000024</ArticleId><ArticleId IdType="pmc">PMC2291482</ArticleId><ArticleId IdType="pubmed">18437207</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa H, Kawasaki A, Oka S, Ito I, Shimada K, Sugii S, et al. Human leukocyte antigens and systemic lupus erythematosus: a protective role for the HLA-DR6 alleles DRB1*13:02 and *14:03. PLoS ONE. 2014;9:e87792 10.1371/journal.pone.0087792</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087792</ArticleId><ArticleId IdType="pmc">PMC3912000</ArticleId><ArticleId IdType="pubmed">24498373</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham RR, Ortmann WA, Langefeld CD, Jawaheer D, Selby SA, Rodine PR, et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet. 2002;71:543&#x2013;553. 10.1086/342290</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/342290</ArticleId><ArticleId IdType="pmc">PMC379191</ArticleId><ArticleId IdType="pubmed">12145745</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo R, Bortolotti D, Bolzani S, Fainardi E. HLA-G Molecules in Autoimmune Diseases and Infections. Front Immunol. 2014;5:592 10.3389/fimmu.2014.00592</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00592</ArticleId><ArticleId IdType="pmc">PMC4235267</ArticleId><ArticleId IdType="pubmed">25477881</ArticleId></ArticleIdList></Reference><Reference><Citation>Carosella ED, Rouas-Freiss N, Roux DT, Moreau P, LeMaoult J. HLA-G: An Immune Checkpoint Molecule. Adv Immunol. 2015;127:33&#x2013;144. 10.1016/bs.ai.2015.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.ai.2015.04.001</ArticleId><ArticleId IdType="pubmed">26073983</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli EC, Ramalho J, Porto IO, Lima TH, Felicio LP, Sabbagh A, et al. Insights into HLA-G genetics provided by worldwide haplotype diversity. Front Immunol. 2014;5:476 10.3389/fimmu.2014.00476</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00476</ArticleId><ArticleId IdType="pmc">PMC4186343</ArticleId><ArticleId IdType="pubmed">25339953</ArticleId></ArticleIdList></Reference><Reference><Citation>Hviid TV, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics. 2003;55:63&#x2013;79. 10.1007/s00251-003-0547-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00251-003-0547-z</ArticleId><ArticleId IdType="pubmed">12712263</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol. 2003;64:1005&#x2013;1010.</Citation><ArticleIdList><ArticleId IdType="pubmed">14602228</ArticleId></ArticleIdList></Reference><Reference><Citation>Martelli-Palomino G, Pancotto JA, Muniz YC, Mendes-Junior CT, Castelli EC, Massaro JD, et al. Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population. PLoS ONE. 2013;8:e71742 10.1371/journal.pone.0071742</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0071742</ArticleId><ArticleId IdType="pmc">PMC3808361</ArticleId><ArticleId IdType="pubmed">24204558</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens. 2008;72:335&#x2013;341. 10.1111/j.1399-0039.2008.01107.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0039.2008.01107.x</ArticleId><ArticleId IdType="pubmed">18700878</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo R, Hviid TV, Govoni M, Padovan M, Rubini M, Melchiorri L, et al. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens. 2008;71:520&#x2013;529. 10.1111/j.1399-0039.2008.01037.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0039.2008.01037.x</ArticleId><ArticleId IdType="pubmed">18380776</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio CR, Veit TD, Monticielo OA, Mucenic T, Xavier RM, Brenol JC, et al. Association of the HLA-G gene +3142C&gt;G polymorphism with systemic lupus erythematosus. Tissue Antigens. 2011;77:540&#x2013;545. 10.1111/j.1399-0039.2011.01635.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0039.2011.01635.x</ArticleId><ArticleId IdType="pubmed">21395561</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucena-Silva N, de Souza VS, Gomes RG, Fantinatti A, Muniz YC, de Albuquerque RS, et al. HLA-G 3' untranslated region polymorphisms are associated with systemic lupus erythematosus in 2 Brazilian populations. J Rheumatol. 2013;40:1104&#x2013;1113. 10.3899/jrheum.120814</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.120814</ArticleId><ArticleId IdType="pubmed">23678155</ArticleId></ArticleIdList></Reference><Reference><Citation>Veit TD, Cordero EA, Mucenic T, Monticielo OA, Brenol JC, Xavier RM, et al. Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus. Lupus. 2009;18:424&#x2013;430. 10.1177/0961203308098187</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203308098187</ArticleId><ArticleId IdType="pubmed">19318395</ArticleId></ArticleIdList></Reference><Reference><Citation>Catamo E, Addobbati C, Segat L, Sotero Fragoso T, Tavares Dantas A, de Ataide Mariz H, et al. Comprehensive analysis of polymorphisms in the HLA-G 5' upstream regulatory and 3' untranslated regions in Brazilian patients with systemic lupus erythematosus. Tissue Antigens. 2015;85:458&#x2013;465. 10.1111/tan.12545</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tan.12545</ArticleId><ArticleId IdType="pubmed">25762019</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu FX, Wu LJ, Luo XY, Tang Z, Yang MH, Xie CM, et al. Lack of association between HLA-G 14-bp polymorphism and systemic lupus erythematosus in a Han Chinese population. Lupus. 2009;18:1259&#x2013;1266. 10.1177/0961203309345756</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309345756</ArticleId><ArticleId IdType="pubmed">19884219</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YH, Bae SC, Song GG. Meta-analysis of associations between functional HLA-G polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int. 2015;35:953&#x2013;961. 10.1007/s00296-014-3155-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-014-3155-3</ArticleId><ArticleId IdType="pubmed">25326335</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Li S, Zhang Y, Lu Y, Wang J, Xu J, et al. Meta-analysis of the relationship between 14bp insertion/deletion polymorphism of HLA-G gene and susceptibility to systemic lupus erythematosus. Hum Immunol. 2014;75:1171&#x2013;1176. 10.1016/j.humimm.2014.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2014.10.008</ArticleId><ArticleId IdType="pubmed">25454623</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, Pan L, et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet. 2007;81:829&#x2013;834. 10.1086/521200</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/521200</ArticleId><ArticleId IdType="pmc">PMC2227932</ArticleId><ArticleId IdType="pubmed">17847008</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirri A, Contieri FC, Benvenutti R, Bicalho Mda G. A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors. Transpl Immunol. 2009;20:143&#x2013;149. 10.1016/j.trim.2008.09.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trim.2008.09.012</ArticleId><ArticleId IdType="pubmed">18926911</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T, Fujii T, Watanabe Y, Tokunaga K, Tadokoro K, Juji T, et al. HLA-G gene polymorphism in a Japanese population. Immunogenetics. 1996;44:186&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">8662085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolte AM, Steffensen R, Nielsen HS, Hviid TV, Christiansen OB. Study of the structure and impact of human leukocyte antigen (HLA)-G-A, HLA-G-B, and HLA-G-DRB1 haplotypes in families with recurrent miscarriage. Hum Immunol. 2010;71:482&#x2013;488. 10.1016/j.humimm.2010.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2010.02.001</ArticleId><ArticleId IdType="pubmed">20149831</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawashima M, Ohashi J, Nishida N, Tokunaga K. Evolutionary analysis of classical HLA class I and II genes suggests that recent positive selection acted on DPB1*04:01 in Japanese population. PLoS One. 2012;7:e46806 10.1371/journal.pone.0046806</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0046806</ArticleId><ArticleId IdType="pmc">PMC3463557</ArticleId><ArticleId IdType="pubmed">23056460</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang TP, Beazley C, Montgomery SB, Dimas AS, Gutierrez-Arcelus M, Stranger BE, et al. Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics. 2010;26:2474&#x2013;2476. 10.1093/bioinformatics/btq452</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq452</ArticleId><ArticleId IdType="pmc">PMC2944204</ArticleId><ArticleId IdType="pubmed">20702402</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike N. Using false discovery rates for multiple comparisons in ecology and evolution. Methods Ecol Evol. 2011;2:278&#x2013;282.</Citation></Reference><Reference><Citation>Benjamini Y, Hochgerg Y. On the adaptive control of the false discovery rate in multiple testing with independent statistics. J Educ Behav Stat. 2000;25:60&#x2013;83.</Citation></Reference><Reference><Citation>Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263&#x2013;265. 10.1093/bioinformatics/bth457</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bth457</ArticleId><ArticleId IdType="pubmed">15297300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hviid TV, Christiansen OB. Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G&#x2014;possible implications for human reproduction and autoimmune disease. Hum Immunol. 2005;66:688&#x2013;699. 10.1016/j.humimm.2005.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2005.03.003</ArticleId><ArticleId IdType="pubmed">15993714</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb R, Kelly JA, Somers EC, Hughes T, Kaufman KM, Sanchez E, et al. Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients. Ann Rheum Dis. 2011;70:151&#x2013;156. 10.1136/ard.2010.141697</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2010.141697</ArticleId><ArticleId IdType="pmc">PMC3034281</ArticleId><ArticleId IdType="pubmed">20881011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirayasu K, Arase H. Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations. J Hum Genet. 2015;60:703&#x2013;708. 10.1038/jhg.2015.64</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jhg.2015.64</ArticleId><ArticleId IdType="pubmed">26040207</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y, Su Y, He J, Yang Y, Shi Y, Cui Y, et al. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjogren's syndrome. Ann Rheum Dis. 2015;74:2070&#x2013;2075. 10.1136/annrheumdis-2013-204441</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-204441</ArticleId><ArticleId IdType="pubmed">24906639</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>